- Home
- BOX vs ACLX Comparison
BOX vs ACLX Comparison
Compare BOX & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | ACLX |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BOX | ACLX |
|---|---|---|
| Price | $24.52 | $68.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $38.00 | ★ $113.75 |
| AVG Volume (30 Days) | ★ 2.9M | 866.7K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.13 | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $1,150,898,000.00 | $35,898,000.00 |
| Revenue This Year | $9.07 | N/A |
| Revenue Next Year | $7.74 | $309.32 |
| P/E Ratio | $19.91 | ★ N/A |
| Revenue Growth | ★ 7.21 | N/A |
| 52 Week Low | $23.70 | $47.86 |
| 52 Week High | $38.80 | $94.07 |
Technical Indicators
Market Signals| Indicator | BOX | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 49.02 |
| Support Level | $23.70 | $66.44 |
| Resistance Level | $25.32 | $71.25 |
| Average True Range (ATR) | 0.82 | 2.70 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 25.29 | 35.00 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.